American Society of Retina Specialists Meeting
American Society of Retina Specialists Meeting
July 30, 2019
2 min watch
Save

VIDEO: Aflibercept ‘greatly reduced’ rates of vision-threatening complications in diabetic retinopathy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the American Society of Retina Specialists meeting, W. Lloyd Clark, MD, discusses his presentation on the PANORAMA study for the treatment of diabetic retinopathy with Eylea (aflibercept, Regeneron) and results at 1 year.